Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Biomarin
Company Monitoring Page for Biomarin
latest headlines for company on cafepharma
How BioMarin Beat Expectations in Q3
Motley Fool
Fri, 11/6/20 - 09:55 am
Tags:
Biomarin
,
hemophilia A
,
earnings
BioMarin nabs FDA review for dwarfism drug vosoritide, forgoes AdComm as it eyes 2021 approval
Fierce Biotech
Wed, 11/4/20 - 10:57 pm
Tags:
Biomarin
,
FDA
,
vosoritide
,
dwarfism
BioMarin (BMRN) Files NDA for Vosoritide to Treat Dwarfism
Yahoo/Zacks.com
Fri, 08/21/20 - 11:56 am
Tags:
Biomarin
,
FDA
,
achondroplasia
,
dwarfism
2 major FDA rejections leave some pharma investors worried about intensification of regulations
Beckers Hospital Review
Thu, 08/20/20 - 10:51 pm
Tags:
FDA
,
drug approvals
,
drug development
,
Gilead Sciences
,
Biomarin
Is valrox dead?
EP Vantage
Thu, 08/20/20 - 11:09 am
Tags:
Biomarin
,
hemophilia A
,
valrox
,
gene therapy
,
Roche
,
Pfizer
,
FDA
FDA gets out its red pen again, rejecting BioMarin's gene therapy valrox amid durability worries
Fierce Biotech
Wed, 08/19/20 - 09:28 am
Tags:
Biomarin
,
FDA
,
valrox
,
hemophilia A
How Biomarin Beat Expectations in Q2
Motley Fool
Wed, 08/5/20 - 09:46 am
Tags:
Biomarin
,
earnings
Go or no go? Valuable drugs set for FDA decisions
EP Vantage
Wed, 07/29/20 - 10:54 am
Tags:
FDA
,
drug approvals
,
Novartis
,
inclisiran
,
Biomarin
,
valrox
,
Roche
,
risdiplam
,
GSK
,
belantamab mafodotin
,
Gilead Sciences
,
Galapagos
,
filgotinib
3 Biotech Stocks With Big Incoming Catalysts
Motley Fool
Sat, 07/25/20 - 02:25 pm
Tags:
FDA
,
GW Pharma
,
Epidiolex
,
filgotinib
,
Galapagos
,
Biomarin
,
valoctocogene roxaparvovec
With cell and gene therapy boom coming, experts at Novartis, Kite trumpet need for capacity: panel
Fierce Pharma
Wed, 06/24/20 - 11:21 pm
Tags:
cell therapy
,
gene therapy
,
Novartis
,
Kite Pharma
,
Biomarin
,
Astellas
BioMarin Shares Additional Promising Phase I/II Data on Hemophilia A Treatment
BioSpace
Wed, 06/17/20 - 10:00 pm
Tags:
Biomarin
,
clinical trials
,
hemophilia A
,
valoctocogene roxaparvovec
BioMarin gene therapy shows sustained benefit in hemophilia A study
Seeking Alpha
Mon, 06/1/20 - 10:42 am
Tags:
Biomarin
,
hemophilia A
,
clinical trials
,
gene therapy
,
valoctocogene roxaparvovec
BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies
Yahoo/PR Newswire
Sun, 05/3/20 - 07:53 pm
Tags:
Biomarin
,
DiNAQOR
,
gene therapy
,
cardiomyopathy
BioMarin Blows Past Q1 Estimates, Projects 1st Year of Profitability in 2020
Motley Fool
Thu, 04/30/20 - 10:25 am
Tags:
Biomarin
,
earnings
10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says
BioSpace
Mon, 03/9/20 - 11:10 pm
Tags:
biosimilars
,
Amgen
,
Allergan
,
Roche
,
Rituxan
,
Bristol-Myers Squibb
,
ozanimod
,
risdiplam
,
Biomarin
,
valrox
BioMarin's Novel Treatment Promises to Disrupt Competitors
Motley Fool
Wed, 02/26/20 - 10:45 am
Tags:
Biomarin
,
gene therapy
,
valrox
,
hemophilia A
FDA Gives BioMarin Pharmaceuticals' Hemophilia Gene Therapy Priority Review
Motley Fool
Thu, 02/20/20 - 11:41 pm
Tags:
FDA
,
Biomarin
,
priority review
,
valrox
,
gene therapy
,
hemophilia A
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
Tags:
drug launches
,
Biohaven
,
rimegepant
,
Novartis
,
ofatumumab
,
Celgene
,
ozanimod
,
Akebia Therapeutics
,
vadadustat
,
Biomarin
,
valrox
,
Gilead Sciences
,
filgotinib
,
Novo Nordisk
,
oral semaglutide
,
inclisiran
,
Immunomedics
,
sacituzumab govitecan
,
AstraZeneca
,
Enhertu
,
Bristol-Myers Squibb
,
liso-cel
Drugmaker BioMarin Seeks New CFO Amid Coming Release Of Potentially Costliest Drug In The World
Forbes
Thu, 02/6/20 - 11:37 pm
Tags:
Biomarin
,
valrox
,
gene therapy
,
hemophilia A
BioMarin Considers $3 Million Price Tag for New Hemophilia Gene Therapy
Motley Fool
Thu, 01/16/20 - 11:27 pm
Tags:
Biomarin
,
JPMHC 2020
,
drug pricing
,
valrox
,
hemophilia
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.